medigraphic.com
ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"

2020, Number 3

<< Back Next >>

Acta Med Cent 2020; 14 (3)

¿Es la comorbilidad cardiovascular la causante de la elevación de la proteína C reactiva en pacientes positivos a la COVID-19?

Pérez FGA

Language: Spanish
References: 14
Page: 304-312
PDF size: 192.16 Kb.


ABSTRACT




REFERENCES

  1. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol [Internet]. 2020 Mar [citado 4 May 2020];92(6):568-575. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25748. https://doi.org/10.1002/jmv.25748

  2. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol [Internet]. 2020 Apr[citado 4 May 2020];92(4):418‐ 423. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681

  3. Cheng P, Zhu H, Witteles RM, Wu JC, Quertermous T, Wu SM, Rhee JW. Cardiovascular risks in patients with COVID-19: potential mechanisms and areas of uncertainty. Curr Cardiol Rep [Internet]. 2020 Apr[citado4 May 2020];22(5):34. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189178/.https://doi.org/10.1007 /s11886-020-01293-2

  4. He XW, Lai JS, Cheng J, Wang MW, Liu YJ, Xiao ZC, et al. Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients. Zhonghua Xin Xue Guan Bing Za Zhi [Internet]. 2020 Mar [citado 4 May 2020];48(0):E011. Disponible en: https://pesquisa.bvsalud.org/global-literatureon- novel-coronavirus-2019-ncov/resource/en/covidwho-8400

  5. Sierra R, Rello J, Bailén MA, Benítez E, Gordillo A, León C, et al. C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med [Internet]. 2004 Sep [citado4 May 2020];30(11):2038-2045. Disponible en: https://link.springer.com/article/10.1007/s00134-004-2434-y

  6. Batún Garrido JAJ, García Padrón OA, Salas Magaña M. Proteína C reactiva como marcador de riesgo cardiovascular en una cohorte de pacientes con artritis reumatoide. Rev Cubana Reumatol [Internet]. 2016 May-Ago [citado 4 May 2020];18(2):111-9. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817- 59962016000200003

  7. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein. Adv Immunol [Internet]. 1983 Jan [citado4 May 2020];34:141-212. Disponible en: https://www.sciencedirect.com/science/article/pii/S006527760860379X?via%3Dih ub

  8. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation [Internet]. 2003 Jan [citado4 May 2020];107(3):363-9. Disponible en: https://www.ahajournals.org/doi/full/10.1161/01.cir.0000053730.47739.3c

  9. Sakkinen P, Abbott RD, Curb JD, RodriguezBl, Yano K, Tracy RP. C-reactive protein and myocardial infarction. J Clin Epidemiol [Internet]. 2002 [citado 4 May 2020];55:445-51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12007546/. https://doi.org/10.1016/S0895-4356(01)00502-9

  10. Jialal I, Devaraj S, Venugopal SK: C-reactive protein: risk marker or mediator in athero thrombosis? Hypertension [Internet]. 2004 Jul [citado 4 May 2020];44(1):6-11. Disponible en: https://www.ahajournals.org/doi/full/10.1161/01.HYP.0000130484.20501.df

  11. Fernández LM. Marcadores de inflamación en enfermedades cardiovasculares. Medicina & Laboratorio [Internet]. 2008 [citado 4 May 2020];14(11-12):547-56. Disponible en: https://www.medigraphic.com/pdfs/medlab/myl-2008/myl0811- 12d.pdf

  12. Palma E, González V, Grünholz D, Landaeta M, Mallea M, Pérez J, et al. Tormenta de citoquinas: reacción adversa inhabitual por rituximab. Caso clínico. Rev Med Chile [Internet]. 2017 Feb [citado 4 May 2020];145(2):260-3. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034- 98872017000200015

  13. Ballou SP, Kushner I. Laboratory evaluation of inflammation. In: Ruddy S, Harris ED, Sledge CB (Eds). Kelley’s Textbook of Rheumatology. Philadelphia, JB Saunders Company; 2001. p. 697-703.

  14. Wilson PW, Nam BH, Pencina M, D’agostino RB, Benjamin EJ, O’donnell CJ.Creactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med [Internet]. 2005 Nov [citado4 May 2020];165(21):2473-8.Disponible en: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/486823




2020     |     www.medigraphic.com